Pharmacological aspects of the coronary circulation.
D000227:Adenine Nucleotides / Q000494:pharmacology; D000787:Angina Pectoris / Q000188:drug therapy; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D016275:Atrial Function; D001794:Blood Pressure; D003327:Coronary Disease / Q000188:drug therapy* / Q000503:physiopathology; D003331:Coronary Vessels / Q000187:drug effects* / Q000502:physiology; D004837:Epinephrine / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology; D006801:Humans; D009206:Myocardium / Q000378:metabolism; D009566:Nitrates / Q000494:pharmacology; D009573:Nitrites / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010101:Oxygen Consumption; D010455:Peptides / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D011299:Prenylamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012039:Regional Blood Flow; D012701:Serotonin / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology*; D014667:Vasopressins / Q000494:pharmacology; D014700:Verapamil / Q000494:pharmacology
D000227:Adenine Nucleotides; D009566:Nitrates; D009573:Nitrites; D010455:Peptides; D010879:Piperazines; D014665:Vasodilator Agents; D014667:Vasopressins; D000804:Angiotensin II; D012701:Serotonin; D006632:Histamine; D011433:Propranolol; D014700:Verapamil; D011299:Prenylamine; D009638:Norepinephrine; D004837:Epinephrine